MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Cara Therapeutics, Inc. (Nasdaq:CARA)*
Organization & Developments: Cara
Parents
Cara Therapeutics, Inc. (Nasdaq:CARA)*
Children
*Clinical-stage small molecule company focused on pain and inflammation
*The Company’s most advanced programs are in the field of kappa opiate receptor agonists and cannabanoid receptor agonists and an
*Treatments for pain and inflammatory disorders.
2016: Cara Therapeutics Q3 Loss Beats Street (CARA)
2016: Cara Therapeutics: Major Upside Potential - Cara Therapeutics Inc. (NASDAQ:CARA)
2016: Why Cara Therapeutics Plunged 37% Last Week (CARA)
2017: Why Cara Theraputics Will Soar - Cara Therapeutics Inc. (NASDAQ:CARA)
2018: Cara Therapeutics - Itching For Big Returns In 2019_seekingalpha.com
2020: Cara Therapeutics Is An Undervalued Asset In 2020_seekingalpha.com
2020: Vifor Pharma and Cara Expand Licensing Deal for Late-Stage Kidney Disease Drug
2021: Cara Therapeutics: Upcoming PDUFA May See Some Upside
2021: Cara's stock tanks as atopic dermatitis phase 2 misses endpoint
2021: Checking Back In On Cara Therapeutics
2021: The Right Call On Cara Therapeutics
2022: Cara Therapeutics: All Eyes On Korsuva Launch Metrics_seekingalpha.com
Jumps
*Key People: Cara
Finance & Acquisitions: Cara